@article{8a9c3d67bfd34f4f9698dcb108c7b7f3,
title = "The Role of Prophylactic Heart Failure Therapy in Duchenne Muscular Dystrophy",
author = "A.K. Lal and C.A. Wittlieb-Weber and C.R. Villa and J. Conway and M.J. Bock and K.E. Gambetta and K.R. Schumacher and S.P. Law and S.R. Deshpande and S.C. West and J.M. Friedland-Little and I.D. Lytrivi and M.A. McCulloch and R.J. Butts and K.R. Knecht and Z. Ou and A.P. Presson and J.N. Johnson and Bock, \{Matthew J.\}",
note = "There is variable practice and debate surrounding prophylactic heart failure (HF) therapy in Duchenne Muscular Dystrophy (DMD) patients with normal systolic function. We sought to determine the impact of HF medications including ACE inhibitors and ARB on the development of moderate systolic dysfunction or death in a cohort of DMD patients.",
year = "2019",
month = apr,
day = "1",
doi = "10.1016/J.HEALUN.2019.01.1187",
language = "American English",
volume = "38",
journal = "Journal of Heart and Lung Transplantation",
}